Arlington Heights, IL, United States of America

JoAnne B Alfaro

This inventor holds 1 USPTO granted patent. Top assignee: Fenwal, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: JoAnne B Alfaro. Retrieved from https://idiyas.com/inventor/joanne-b-alfaro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: JoAnne B Alfaro: Innovator in Biological Fluid Processing

Introduction

JoAnne B Alfaro is a notable inventor based in Arlington Heights, IL. She has made significant contributions to the field of biological fluid processing. Her innovative work focuses on methods for the reduction of leukocytes in biological fluids, which has important implications for medical treatments.

Latest Patents

JoAnne holds 1 patent for her invention titled "Methods and systems for the reduction of leukocytes in a biological fluid." This patent discloses methods and systems designed to remove leukocytes from biological fluids. The innovative approach includes a chamber containing particles that leukocytes adhere to, which may carry an electrostatic charge. In one example, the particles consist of a polymer with an acid number of 5 or greater.

Career Highlights

JoAnne is currently employed at Fenwal, Inc., where she continues to develop her expertise in biological fluid processing. Her work at Fenwal has allowed her to contribute to advancements in medical technologies that enhance patient care.

Collaborations

JoAnne collaborates with her coworker, Yoshikazu Mizobuchi, who shares her commitment to innovation in the field.

Conclusion

JoAnne B Alfaro's contributions to the reduction of leukocytes in biological fluids exemplify her dedication to improving medical technologies. Her innovative methods have the potential to significantly impact patient treatment and care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…